Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent
Purpose: Muscle, bone and tendon regeneration depend on the microperfusion of the corresponding tissue which can be quantified with contrast-enhanced ultrasound (CEUS) using sulfur hexafluoride contrast agent (SonoVue (R)). This study investigated the incidence of adverse events (AEs) in musculoskel...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 April 2020
|
| In: |
Therapeutics and clinical risk management
Year: 2020, Jahrgang: 16, Pages: 269-280 |
| ISSN: | 1178-203X |
| DOI: | 10.2147/TCRM.S235235 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.2147/TCRM.S235235
|
| Verfasserangaben: | Christian Fischer, Pierre Kunz, Marten Strauch, Marc-Andre Weber, Julian Doll |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 169802696X | ||
| 003 | DE-627 | ||
| 005 | 20240527152904.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200512s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/TCRM.S235235 |2 doi | |
| 035 | |a (DE-627)169802696X | ||
| 035 | |a (DE-599)KXP169802696X | ||
| 035 | |a (OCoLC)1264354741 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fischer, Christian |d 1979- |e VerfasserIn |0 (DE-588)1167802500 |0 (DE-627)1031300945 |0 (DE-576)511278608 |4 aut | |
| 245 | 1 | 0 | |a Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent |c Christian Fischer, Pierre Kunz, Marten Strauch, Marc-Andre Weber, Julian Doll |
| 264 | 1 | |c 14 April 2020 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.05.2020 | ||
| 520 | |a Purpose: Muscle, bone and tendon regeneration depend on the microperfusion of the corresponding tissue which can be quantified with contrast-enhanced ultrasound (CEUS) using sulfur hexafluoride contrast agent (SonoVue (R)). This study investigated the incidence of adverse events (AEs) in musculoskeletal patients and gives an overview of musculoskeletal CEUS applications. Patients and Methods: Based on 13 studies in a standardized monocentric setting, a total of 2268 CEUS examinations in 764 patients were performed and AEs due to the administration of sulfur hexafluoride contrast agent were classified as either mild, moderate or severe. Results: No fatal events occurred. AEs were reported in three cases, of which only one was classified as severe and two as mild. The total rate of all AEs was 0.13% and 0.04% for severe AEs. Conclusion: The present analysis confirms the safety of musculoskeletal CEUS using sulfur hexafluoride contrast agent with a lower rate of AEs than that reported for other contrast agents even in elderly patients with concomitant diseases. | ||
| 650 | 4 | |a adverse events | |
| 650 | 4 | |a adverse-reactions | |
| 650 | 4 | |a ceus | |
| 650 | 4 | |a contrast agents | |
| 650 | 4 | |a contrast-enhanced ultrasound | |
| 650 | 4 | |a gadolinium deposition | |
| 650 | 4 | |a liver-lesions | |
| 650 | 4 | |a media | |
| 650 | 4 | |a musculoskeletal | |
| 650 | 4 | |a sonography | |
| 650 | 4 | |a sonovue | |
| 650 | 4 | |a sulfur hexafluoride | |
| 650 | 4 | |a vascularity | |
| 700 | 1 | |a Kunz, Pierre |d 1975- |e VerfasserIn |0 (DE-588)132936666 |0 (DE-627)528689487 |0 (DE-576)265631335 |4 aut | |
| 700 | 1 | |a Strauch, Marten |d 1986- |e VerfasserIn |0 (DE-588)1328727203 |0 (DE-627)1888145552 |4 aut | |
| 700 | 1 | |a Weber, Marc-André |d 1973- |e VerfasserIn |0 (DE-588)142373044 |0 (DE-627)704211432 |0 (DE-576)330376802 |4 aut | |
| 700 | 1 | |a Doll, Julian |d 1987- |e VerfasserIn |0 (DE-588)1121242170 |0 (DE-627)874186609 |0 (DE-576)480777918 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapeutics and clinical risk management |d Albany, Auckland : Dove Medical Press, 2005 |g 16(2020), Seite 269-280 |h Online-Ressource |w (DE-627)481905820 |w (DE-600)2180573-8 |w (DE-576)34727062X |x 1178-203X |7 nnas |a Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent |
| 773 | 1 | 8 | |g volume:16 |g year:2020 |g pages:269-280 |g extent:12 |a Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent |
| 856 | 4 | 0 | |u https://doi.org/10.2147/TCRM.S235235 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200512 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1121242170 |a Doll, Julian |m 1121242170:Doll, Julian |d 910000 |d 911460 |e 910000PD1121242170 |e 911460PD1121242170 |k 0/910000/ |k 1/910000/911460/ |p 5 |y j | ||
| 998 | |g 142373044 |a Weber, Marc-André |m 142373044:Weber, Marc-André |d 50000 |e 50000PW142373044 |k 0/50000/ |p 4 | ||
| 998 | |g 132936666 |a Kunz, Pierre |m 132936666:Kunz, Pierre |d 910000 |d 911460 |e 910000PK132936666 |e 911460PK132936666 |k 0/910000/ |k 1/910000/911460/ |p 2 | ||
| 998 | |g 1167802500 |a Fischer, Christian |m 1167802500:Fischer, Christian |d 910000 |d 911460 |e 910000PF1167802500 |e 911460PF1167802500 |k 0/910000/ |k 1/910000/911460/ |p 1 |x j | ||
| 999 | |a KXP-PPN169802696X |e 3664869133 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Christian Fischer, Pierre Kunz, Marten Strauch, Marc-Andre Weber, Julian Doll"]},"id":{"eki":["169802696X"],"doi":["10.2147/TCRM.S235235"]},"physDesc":[{"extent":"12 S."}],"recId":"169802696X","person":[{"role":"aut","given":"Christian","family":"Fischer","display":"Fischer, Christian"},{"display":"Kunz, Pierre","given":"Pierre","role":"aut","family":"Kunz"},{"display":"Strauch, Marten","family":"Strauch","role":"aut","given":"Marten"},{"family":"Weber","role":"aut","given":"Marc-André","display":"Weber, Marc-André"},{"display":"Doll, Julian","given":"Julian","role":"aut","family":"Doll"}],"relHost":[{"origin":[{"publisher":"Dove Medical Press","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisherPlace":"Albany, Auckland"}],"title":[{"title_sort":"Therapeutics and clinical risk management","title":"Therapeutics and clinical risk management"}],"note":["Gesehen am 21.11.2022","Volltext auch als Teil einer Datenbank verfügbar"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"481905820","physDesc":[{"extent":"Online-Ressource"}],"disp":"Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agentTherapeutics and clinical risk management","titleAlt":[{"title":"Journal of therapeutics and clinical risk management"}],"pubHistory":["1.2005 -"],"part":{"year":"2020","pages":"269-280","extent":"12","volume":"16","text":"16(2020), Seite 269-280"},"id":{"eki":["481905820"],"issn":["1178-203X"],"zdb":["2180573-8"],"doi":["10.2147/TCRM"]}}],"origin":[{"dateIssuedDisp":"14 April 2020","dateIssuedKey":"2020"}],"note":["Gesehen am 12.05.2020"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent","title_sort":"Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent"}]} | ||
| SRT | |a FISCHERCHRSAFETYPROF1420 | ||